衛教資訊
衛教單張
Health Education ResourcesGefitinib 化學藥物艾瑞莎IRESSA用藥指導
2024/1/22Gefitinib is a receptor tyrosine kinase inhibitor which targets the epidermal growth factor receptor (EGFR) on cells. EGFR is found in large amounts on the surface of some cancer cells, resulting in tumors growing more quickly. Gefitinib blocks the function of EGFR, thus preventing further cancer cell growth and slowing cancer progression.
Erlotinib 口服化學藥物得舒緩用藥指導
2024/1/22Erlotinib is a receptor tyrosine kinase inhibitor that targets on the epidermal growth factor receptor (EGFR) on cells. EGFR is found in large amounts on the surface of some cancer cells, resulting in tumors growing more quickly.
Abraxane 認識化療藥品Abraxane
2024/1/22Abraxane® is an albumin-bound form of paclitaxel. Albumin is a protein found in the blood. Paclitaxel is a plant alkaloid derived from the bark of the Pacific Yew tree.
Aflibercept 認識化療藥品Aflibercept
2024/1/22Aflibercept is a monoclonal antibody that targets to the protein called vascular endothelial growth factor-A (VEGF-A), VEGF-B and placental growth factor (PIGF), thereby inhibiting the binding of these proteins to its receptors.
Arsenic Trioxide 認識化療藥品Arsenic Trioxide
2024/1/22Arsenic trioxide is a natural element that is used to treat patients with acute promyelocytic leukemia. The mechanisms of arsenic trioxide on cancer cell death is not clearly understood.
Azacitidine 認識化療藥品Azacitidine
2024/1/22Azacitidine is classified as an anticancer antimetabolites. This drug kills abnormal blood cells in bone marrow that have grown too fast and do not work properly.
Bendamustine 認識化療藥品Bendamustine
2024/1/22Bendamustine is an alkylating agent that exerts its anticancer activity by reacting with DNA and interfering with DNA replication and cell division. This stops the growth and spread of cancer cell in the body.
Bortezomib 認識標靶藥品Bortezomib
2024/1/22Bortezomib is a proteasome inhibitor. A proteasome is an enzyme that is responsible for breaking down proteins in cells. By blocking the action of proteasome, waste proteins build up in myeloma cells, and cause them to die.
Brentuximab vedotin 認識化療藥品Brentuximab
2024/1/22Adcetris® is an antibody-drug conjugate combining a cytotoxic agent with a selective monoclonal antibody, which targets a protein called CD30 on the surface of some lymphoma cells, and delivers a cytotoxic agent to destroy the cancer cells.
Busulfan 認識化療藥品Busulfan
2024/1/22Busulfan is an alkylating agent that exerts its anticancer activity by reacting with DNA and interfering with DNA replication and cell division. This stops the growth and spread of cancer cell in the body.
統計數據
3064 篇
1915 篇
407 篇